Which class of drugs is categorized as acetylcholinesterase inhibitors in Alzheimer's treatment?

Acetylcholinesterase inhibitors are a class of drugs used in the management of Alzheimer's disease, and they work by preventing the breakdown of acetylcholine, a neurotransmitter involved in memory and learning. Donepezil and Rivastigmine are both well-known examples of these inhibitors.

Donepezil specifically helps to enhance cholinergic function by inhibiting the enzyme acetylcholinesterase, which results in increased levels of acetylcholine in the brain. This can help improve cognitive function in patients with mild to moderate Alzheimer's disease.

Rivastigmine operates similarly by also inhibiting acetylcholinesterase, thereby increasing acetylcholine levels. It is prescribed for both mild and moderate Alzheimer's, and in some cases, it is also used in Parkinson's disease dementia.

Since both Donepezil and Rivastigmine are classified as acetylcholinesterase inhibitors, the correct answer encompasses both medications, making "both Donepezil and Rivastigmine" the appropriate choice. This highlights the therapy's goal in Alzheimer's treatment, which is to improve cognitive symptoms through the modulation of acetylcholine levels in the brain.